Content
01/10/2024
Medford, MA USA
Myrobalan Therapeutics
completed $24 million Series A Round funding. Investors include
Co-win Ventures (lead), 3E Bioventures, AB Magnitude Ventures Group.
About
Developing therapeutics to address the unmet need and societal burdens posed by neurodegenerative, demyelinating and neuropsychiatric disorders.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
